We are live on ! Find out more
OCM

Oakview Capital Management Portfolio holdings

AUM $21.6M
1-Year Est. Return 20.25%
This Fund
S&P 500
This Quarter Est. Return
-17.81%
1 Year Est. Return
+20.25%
3 Year Est. Return
+21.24%
5 Year Est. Return
+60.68%
10 Year Est. Return
AUM
$270M
AUM Growth
-$10M
Cap. Flow
+$44M
Cap. Flow %
16.31%
Top 10 Hldgs %
78.84%
Holding
15
New
1
Increased
10
Reduced
4
Closed

Top Sells

1
ENOV icon
Enovis
ENOV
+$19M
2
PFE icon
Pfizer
PFE
+$10.5M
3
TMUS icon
T-Mobile US
TMUS
+$10.4M
4
GM icon
General Motors
GM
+$517K

Sector Composition

1 Healthcare 28.77%
2 Financials 19.68%
3 Materials 12.96%
4 Energy 11.39%
5 Consumer Discretionary 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIG icon
1
American International
AIG
$42.7B
$30.9M 11.47%
784,716
+346,573
+79% +$15.1M
GM icon
2
General Motors
GM
$68.6B
$23.3M 8.63%
695,814
-14,990
-2% -$517K
COHR
3
DELISTED
Coherent Inc
COHR
$22.7M 8.41%
214,363
+120,154
+128% +$15.4M
CB icon
4
Chubb
CB
$137B
$22.1M 8.21%
171,231
+55,669
+48% +$7.19M
CAH icon
5
Cardinal Health
CAH
$53.5B
$20.9M 7.75%
468,489
+9,865
+2% +$514K
DD icon
6
DuPont de Nemours
DD
$18.3B
$20.6M 7.62%
151,757
+65,349
+76% +$9.38M
OFIX icon
7
Orthofix Medical
OFIX
$468M
$18.7M 6.92%
355,424
+65,902
+23% +$3.75M
NTAP icon
8
NetApp
NTAP
$32.1B
$18.3M 6.78%
306,517
+103,572
+51% +$7.45M
CNXM
9
DELISTED
CNX Midstream Partners LP
CNXM
$17.9M 6.64%
1,098,698
+75,433
+7% +$1.36M
ALEX
10
DELISTED
Alexander & Baldwin
ALEX
$17.3M 6.4%
939,090
+288,943
+44% +$5.82M
PFE icon
11
Pfizer
PFE
$143B
$15.3M 5.69%
370,331
-252,882
-41% -$10.5M
TMUS icon
12
T-Mobile US
TMUS
$208B
$14.5M 5.39%
228,327
-155,192
-40% -$10.4M
FMC icon
13
FMC
FMC
$1.4B
$14.4M 5.33%
224,165
+25,954
+13% +$1.82M
ROAN
14
DELISTED
Roan Resources, Inc.
ROAN
$12.8M 4.75%
+1,528,464
New +$16.5M
ENOV icon
15
Enovis
ENOV
$1.56B
$2K ﹤0.01%
64
-406,538
-100% -$19M

Similar funds

Oakview Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Oakview Capital Management held 15 positions worth $270M, down 3.6% from $280M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Oakview Capital Management deployed $44M of net new capital in Q4 2018, opening 1 new position and adding to 10 existing holdings. Its largest new stake was Roan Resources, Inc.: 1,528,464 shares worth $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 39% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Enovis, an estimated $19M trimmed.

  • Oakview Capital Management's largest Q4 2018 buy was Roan Resources, Inc.: 1,528,464 shares worth $12.8M.
  • Oakview Capital Management added most to Coherent Inc in Q4 2018, an estimated $15.4M increase.
  • Oakview Capital Management's biggest Q4 2018 reduction was Enovis, cutting an estimated $19M.
  • Oakview Capital Management's ten largest holdings make up 79% of its $270M portfolio in Q4 2018.
  • Oakview Capital Management opened 1 new position and closed 0 in Q4 2018.
  • Oakview Capital Management's portfolio value fell 3.6% quarter-over-quarter to $270M.

Based on Oakview Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.